Description
SWOT ANALYSIS OF DAIICHI SANKYO
Daiichi Sankyo
Parent Company
Daiichi Sankyo
Category
Pharmaceutical
Sector
Healthcare
Tagline/ Slogan
Passion for innovation, Compassion for patients
USP
It is one of the largest pharmaceutical company in Japan
STP
Segment
Oncology & Cardiovascular diseases
Healthcare professionals offereing treatments to patients suffering from Target Group cancer or cardiovascular disease
They are global pharma innovator who aim to provide pharmaceuticals Positioning in shortest possible time
SWOT Analysis
1. Has a strong workforce of over 30,000 employees 2. Leading producer of Benicar which is angiotensin II receptor antagonist 3. It is one of the largest pharmaceutical company in Japan 4. Strong presence in US, Europe, India, China, Brazil, Thailand and some others Strength 5. Strong brand establishment through many major acquisitions
1. Despite being a strong brand, had a limited market share due to international competitors 2. Operates in limited segments such as Oncology & Cardiovascular Weakness segment
1. Increasing world population and more awareness about health 2. More people suffering from chronic diseases such as cancer, cardiovascular diseases Opportunity 3. Increasing awareness of healthcare solutions
1. Natural disasters in Japan 2. increasing stringency in drug development guidelines Threats 3. Global economic slowdown
Competition
1. Takeda Pharmaceuticals 2. Teva pharmaceuticals 3. Astellas pharmaceuticals Competitors 4. AstraZeneca
doc_392770210.docx
SWOT ANALYSIS OF DAIICHI SANKYO
Daiichi Sankyo
Parent Company
Daiichi Sankyo
Category
Pharmaceutical
Sector
Healthcare
Tagline/ Slogan
Passion for innovation, Compassion for patients
USP
It is one of the largest pharmaceutical company in Japan
STP
Segment
Oncology & Cardiovascular diseases
Healthcare professionals offereing treatments to patients suffering from Target Group cancer or cardiovascular disease
They are global pharma innovator who aim to provide pharmaceuticals Positioning in shortest possible time
SWOT Analysis
1. Has a strong workforce of over 30,000 employees 2. Leading producer of Benicar which is angiotensin II receptor antagonist 3. It is one of the largest pharmaceutical company in Japan 4. Strong presence in US, Europe, India, China, Brazil, Thailand and some others Strength 5. Strong brand establishment through many major acquisitions
1. Despite being a strong brand, had a limited market share due to international competitors 2. Operates in limited segments such as Oncology & Cardiovascular Weakness segment
1. Increasing world population and more awareness about health 2. More people suffering from chronic diseases such as cancer, cardiovascular diseases Opportunity 3. Increasing awareness of healthcare solutions
1. Natural disasters in Japan 2. increasing stringency in drug development guidelines Threats 3. Global economic slowdown
Competition
1. Takeda Pharmaceuticals 2. Teva pharmaceuticals 3. Astellas pharmaceuticals Competitors 4. AstraZeneca
doc_392770210.docx